Showing 2421-2430 of 2656 results for "".
- New Research Suggests Glaucoma Screening Could Save Three Million Years Of Blindness In Chinahttps://modernod.com/news/new-research-suggests-glaucoma-screening-could-save-three-million-years-of-blindness-in-china/2476692/New research by Orbis International, Queen’s University Belfast, and Wenzhou Medical University has found that offering glaucoma screening in China could be highly cost-effective while reducing blindness among the population. The novel findings could change
- Alimera’s Iluvien Receives Positive NICE Recommendation for Noninfectious Posterior Uveitishttps://modernod.com/news/alimeras-iluvien-receives-positive-nice-recommendation-for-noninfectious-posterior-uveitis/2476675/Alimera Sciences announced that the United Kingdom’s National Institute for Health and Care Excellence (NICE), in its Final Appraisal Determination for national reimbursement, has recommended funding for Iluvien 190 micrograms intravitreal implant in applicator for the prevention of relapse
- Harrow Health to Locate Headquarters in Nashville, Tennesseehttps://modernod.com/news/harrow-health-to-locate-headquarters-in-nashville-tennessee/2476667/Harrow Health announced that the company will relocate its headquarters from San Diego to Nashville, Tennessee. “From our new home in Nashville, our team will continue to start, finance and grow pharmaceutical companies that will develop innovative, affordable and accessible medicines to s
- Valeda Light Delivery System Receives 2019 Medical Design Excellence Awardhttps://modernod.com/news/valeda-light-delivery-system-receives-2019-medical-design-excellence-award/2476654/LumiThera and Product Creation Studio announced that LumiThera’s Valeda Light Delivery System has won a silver award in the 21st Annual Medical Design Excellence Awards competition. The 2019 winners were announced at the MDEA Ceremony on Tuesday, June 11, 2
- Ocular Therapeutix OTX-TP Intracanalicular Insert Fails to Meet Phase 3 Endpointhttps://modernod.com/news/ocular-therapeutix-otx-tp-intracanalicular-insert-fails-to-meet-phase-3-endpoint/2476598/Ocular Therapeutix’s intracanalicular insert failed to meet its primary endpoint of statistically significant superiority in mean reduction of IOP compared with placebo at all nine time points, according to a company news release. OTX-TP is an intracanalicular insert that delivers a
- Surgical Specialties Launches Caliber Ophthalmics Division to Focus on Global Growth of Ophthalmic Surgical Procedureshttps://modernod.com/news/surgical-specialties-launches-caliber-ophthalmics-division-to-focus-on-global-growth-of-ophthalmic-surgical-procedures/2476597/Surgical Specialties Corporation (SSC) announced the launch of Caliber Ophthalmics, a new business division that combines SSC’s Sharpoint brand with its two recent ophthalmic acquisitions, Unique Technologies and VPM Surgical. To lead the Caliber Ophthalmics division, SSC has named <
- Physicians, Patients Overwhelmingly Support FDA Distinct Biologic Naming Plan, Suffixes for New Productshttps://modernod.com/news/physicians-patients-overwhelmingly-support-fda-distinct-biologic-naming-plan-suffixes-for-new-products/2476581/US physicians and patient advocacy organizations expressed their support for the FDA’s suffix-based naming system for biologic medicines and biosimilars, according to The Alliance for Safe Biologic Medicines. Comments were electronically submitted last week to the agency. Biologic me
- States Bring Price Fixing Suit Against Generic Drug Makershttps://modernod.com/news/states-bring-price-fixing-suit-against-generic-drug-makers/2476576/Attorneys general from more than 40 states are alleging the nation’s largest generic drug manufacturers conspired to artificially inflate and manipulate prices for more than 100 different generic drugs, including treatments for diabetes, cancer, arthritis, and other medical conditions, acco
- Optimo Medical AG Wins the ZKB Pioneer Prize in Switzerlandhttps://modernod.com/news/optimo-medical-ag-wins-the-zkb-pioneer-prize-in-switzerland/2476568/Optimo Medical’s eye surgery planning software Optimeyes was named the 2019 winner of the zkb pioneer prize, awarding the company a cheque for 98,696 Swiss Franc ($96,845 US). Optimo Medical was chosen from over 50 other startups in many industries from across Switzerland. Since 2001
- Nick Mamalis, MD, Named 2019 ASCRS President as ASCRS Unveils New Brandinghttps://modernod.com/news/nick-mamalis-md-named-2019-ascrs-president-as-ascrs-unveils-new-branding/2476560/Nick Mamalis, MD, a well-known ophthalmologist and longtime co-editor of the Journal of Cataract & Refractive Surgery, assumed his role as president of the American Society of Cataract and Refractive Surgery (ASCRS) during the ASCRS meeting’s opening general session here this p